The story of Sildenafil presents a complex case for observers in the pharmaceutical sector. While initially a blockbuster success, producing billions, the intellectual property expiration and the subsequent flood of https://pharma439063.mdkblog.com/47927872/viagra-and-big-pharma-a-hazardous-investment